Fundraising Fox

Gilgamesh Pharma

New York, US · Founded 2025 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

AK
Andrew KruegelExecutive Officer, Director
ZH
Zia HuqueDirector
RB
Robert BermanDirector
PS
Phil SkolnickDirector
JS
Jonathan SpornExecutive Officer, Director
AK
Amy KruseDirector

Investors · 1

Prime Movers LabreportedJackson · $2M – $30Mvia Zia Huque · board

Reported raises · per SEC filings

Form D private placements
▶$2.3MraisedMar 2026 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Amy KruseDirector
  • Jonathan SpornExecutive Officer, Director
  • Phil SkolnickDirector
  • Zia HuqueDirector
  • Robert BermanDirector
  • Andrew KruegelExecutive Officer, Director
Offering amount
$15M
Amount sold
$2.3M
Minimum investment
$50K
First sale
Mar 2026
Incorporated
Corporation, Delaware, 2025
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$60MraisedMar 2026 · 40 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Amy KruseDirector
  • Zia HuqueDirector
  • Robert BermanDirector
  • Phil SkolnickDirector
  • Jonathan SpornExecutive Officer, Director
  • Andrew KruegelExecutive Officer, Director
Offering amount
$60M
Amount sold
$60M
Minimum investment
$50K
First sale
Mar 2026
Incorporated
Corporation, Delaware, 2025
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.4MofferedFeb 2026 · 8 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Phil SkolnickDirector
  • Robert BermanDirector
  • Zia HuqueDirector
  • Amy KruseDirector
  • Andrew KruegelExecutive Officer, Director
  • Jonathan SpornExecutive Officer, Director
Offering amount
$4.4M
Minimum investment
$27
Incorporated
Corporation, Delaware, 2025
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.1MraisedFeb 2026 · 9 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew KruegelExecutive Officer, Director
  • Zia HuqueDirector
  • Robert BermanDirector
  • Phil SkolnickDirector
  • Jonathan SpornExecutive Officer, Director
  • Amy KruseDirector
Offering amount
$6.1M
Amount sold
$6.1M
Minimum investment
$27.6K
First sale
Jan 2026
Incorporated
Corporation, Delaware, 2025
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.